16 ML bevacizumab-maly 25 MG/ML Injection [Alymsys]
RxNorm concept 2599052, branded drug (sbd). Prescribable name: Alymsys 400 MG in 16 ML Injection.
- RxCUI
- 2599052
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2599052 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Alymsys 25 MG/ML per 16 ML Injection; Alymsys 400 MG per 16 ML Injection
Related concepts
- bevacizumab-maly 25 MG/ML (SCDC, consists of)
- bevacizumab-maly 25 MG/ML [Alymsys] (SBDC, consists of)
- Injection (DF, has dose form)
- Alymsys (BN, has ingredient)
- 16 ML bevacizumab-maly 25 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2599052 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2599052 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2599052. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.